Publications from our Alumni Trainees:

 
 

Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic.  Tiendrebeogo T, Plazy M, Darak S, Miric M, Perez-Then E, Butsashvili M, Tchendjou P, Dabis F, Orne-Gliemann J. BMC Public Health. 2017 Nov 25;17(1):901. doi: 10.1186/s12889-017-4901-8.

 

Progress Toward Achieving the UNAIDS 90-90-90 Goals in HIV Care From Diagnosis to Durable Viral Suppression in the Country of Georgia. Chkhartishvili N, Chokoshvili O, Abutidze A, Dvali N, Del Rio C, Tsertsvadze T.  AIDS Res Hum Retroviruses. 2017 Oct;33(10):999-1003. doi: 10.1089/AID.2016.0103. Epub 2017 Jan 27.

Late presentation of HIV infection in the country of Georgia: 2012-2015. Chkhartishvili N, Chokoshvili O, Bolokadze N, Tsintsadze M, Sharvadze L, Gabunia P, Dvali N, Abutidze A, Tsertsvadze T. PLoS One. 2017 Oct 30;12(10):e0186835. doi: 10.1371/journal.pone.0186835. eCollection 2017.

The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination - Georgia, 2015-2016. Nasrullah M, Sergeenko D, Gvinjilia L, Gamkrelidze A, Tsertsvadze T, Butsashvili M, Metreveli D, Sharvadze L, Alkhazashvili M, Shadaker S, Ward JW, Morgan J, Averhoff F. MMWR Morb Mortal Wkly Rep. 2017 Jul 28;66(29):773-776. doi: 10.15585/mmwr.mm6629a2.

 

Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis. Kassai S, Pintér JN, Rácz J, Böröndi B, Tóth-Karikó T, Kerekes K, Gyarmathy VA. Harm Reduct J. 2017 Feb 10;14(1):9. doi: 10.1186/s12954-017-0138-1.

Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience. Dolmazashvili E1, Abutidze A, Chkhartishvili N, Karchava M, Sharvadze L, Tsertsvadze T. Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1223-1230. doi: 10.1097/MEG.0000000000000964.

 

Islamic Influence on HIV Risk and Protection Among Central Asian Male Migrant Workers in Kazakhstan. Shaw SA, McCrimmon T, Mergenova G, Sultangaliyeva A, El-Bassel N. Qual Health Res. 2017 Aug;27(10):1553-1561. doi: 10.1177/1049732317697101. Epub 2017 Mar 20.

What Prevents Central Asian Migrant Workers from Accessing HIV Testing? Implications for Increasing HIV Testing Uptake in Kazakhstan. Davis A, Terlikbayeva A, Terloyeva D, Primbetova S, El-Bassel N. AIDS Behav. 2017 Aug;21(8):2372-2380. doi: 10.1007/s10461-017-1713-x.

 

Prevalence and genotypes of GBV-C and its associations with HIV infection among persons who inject drugs in Eastern Europe. Jõgeda EL, Huik K, Pauskar M, Kallas E, Karki T, Des Jarlais D, Uusküla A, Lutsar I, Avi R. J Med Virol. 2017 Apr;89(4):632-638. doi: 10.1002/jmv.24683. Epub 2016 Sep 16.

Factors associated with urinary tract infections among HIV-1 infected patients. Skrzat-Klapaczyńska A, Matłosz B, Bednarska A, Paciorek M, Firląg-Burkacka E, Horban A, Kowalska JD. PLoS One. 2018 Jan 11;13(1):e0190564. doi: 10.1371/journal.pone.0190564. eCollection 2018.

 

Harm reduction-based and peer-supported hepatitis C treatment for people who inject drugs in Georgia. Kikvidze T, Luhmann N, Avril E, Butsashvili M, Labartkava K, Etienne A, Le Pluart D, Inaridze I, Gamezardashvili A, Kharshiladze D, Bouscaillou J. Int J Drug Policy. 2018 Feb;52:16-19. doi: 10.1016/j.drugpo.2017.11.014. Epub 2017 Dec 9.

 

Epidemiology of human immunodeficiency virus (HIV) drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia. Karkashadze E, Dvali N, Bolokadze N, Sharvadze L, Gabunia P, Karchava M, Tchelidze T, Tsertsvadze T, DeHovitz J, Del Rio C, Chkhartishvili N. J Med Virol. 2019 Feb;91(2):235-240. doi: 10.1002/jmv.25245. Epub 2018 Oct 17.

Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program. Karchava M, Chkhartishvili N, Sharvadze L, Abutidze A, Dvali N, Gatserelia L, Dzigua L, Bolokadze N, Dolmazashvili E, Kotorashvili A, Imnadze P, Gamkrelidze A, Tsertsvadze T. Hepatol Res. 2018 Jan;48(1):36-44. doi: 10.1111/hepr.12890. Epub 2017 Apr 24.

Rates and risk factors for human cutaneous anthrax in the country of Georgia: National surveillance data, 2008-2015. Kasradze A, Echeverria D, Zakhashvili K, Bautista C, Heyer N, Imnadze P, Mirtskhulava V. PLoS One. 2018 Feb 7;13(2):e0192031. doi: 10.1371/journal.pone.0192031. eCollection 2018.

Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine. Mazhnaya A, Marcus R, Bojko MJ, Zelenev A, Makarenko I, Pykalo I, Filippovych S, Dvoriak S, Altice FL. J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):288-295. doi: 10.1097/QAI.0000000000001827.

 

Microfinance for women at high risk for HIV in Kazakhstan: study protocol for a cluster-randomized controlled trial. McCrimmon T, Witte S, Mergenova G, Terlikbayeva A, Primbetova S, Kuskulov A, Bellamy SL, El-Bassel N. Trials. 2018 Mar 20;19(1):187. doi: 10.1186/s13063-018-2566-y.

 

Sexual Risks and Policing among Male Migrant and Non-migrant Market Vendors in Central Asia. Marotta P, El-Bassel N, Terlikbayeva A, Mergenova G, Primbetova S, Wu E, Gilbert L. J Urban Health. 2018 Feb;95(1):116-128. doi: 10.1007/s11524-017-0171-0.

Generational differences in current sexual behavior among Georgian reproductive-aged women. Abzianidze T, Butsashvili M, Kajaia M, DeHovitz JA, Kamkamidze G. Int J Womens Health. 2019 May 6;11:301-308. doi: 10.2147/IJWH.S197473. eCollection 2019.

Racial disparity in maternal phthalates exposure; Association with racial disparity in fetal growth and birth outcomes. Bloom MS, Wenzel AG, Brock JW, Kucklick JR, Wineland RJ, Cruze L, Unal ER, Yucel RM, Jiyessova A, Newman RB. Environ Int. 2019 Jun;127:473-486. doi: 10.1016/j.envint.2019.04.005. Epub 2019 Apr 10.

Identifying risk factors associated with smear positivity of pulmonary tuberculosis in Kazakhstan. Hermosilla S, You P, Aifah A, Abildayev T, Akilzhanova A, Kozhamkulov U, Muminov T, Darisheva M, Zhussupov B, Terlikbayeva A, El-Bassel N, Schluger N. PLoS One. 2017 Mar 1;12(3):e0172942. doi: 10.1371/journal.pone.0172942. eCollection 2017.

 

Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P. Lancet Infect Dis. 2018 Dec;18(12):1397-1409. doi: 10.1016/S1473-3099(18)30469-9. Epub 2018 Oct 29.

Untreated depression among persons living with human immunodeficiency virus in Kazakhstan: A cross-sectional study. Terloyeva D, Nugmanova Z, Akhmetova G, Akanov A, Patel N, Lazariu V, Norelli L, McNutt LA. PLoS One. 2018 Mar 28;13(3):e0193976. doi: 10.1371/journal.pone.0193976. eCollection 2018.

Identification of recombinant strains in HCV genotype 1 and 3: Is it needed?  Zarkua J, Zakalashvili M, Gish RG, Metreveli D. Liver Int. 2018 May;38(5):958. doi: 10.1111/liv.13729. Epub 2018 Mar 25. No abstract available.

 

Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.  Zakalashvili M, Zarkua J, Weizenegger M, Bartel J, Raabe M, Zangurashvili L, Kankia N, Jashiashvili N, Lomidze M, Telia T, Kerashvili V, Zhamutashvili M, Abramishvili N, Hedskog C, Chodavarapu K, Brainard DM, McHutchison JG, Mo H, Svarovskaia E, Gish RG, Rtskhiladze I, Metreveli D. Liver Int. 2018 Mar;38(3):451-457. doi: 10.1111/liv.13540. Epub 2017 Sep 2.

Prevalence, diversity, and host associations of Bartonella strains in bats from Georgia (Caucasus). Urushadze L, Bai Y, Osikowicz L, McKee C, Sidamonidze K, Putkaradze D, Imnadze P, Kandaurov A, Kuzmin I, Kosoy M. PLoS Negl Trop Dis. 2017 Apr 11;11(4):e0005428. doi: 10.1371/journal.pntd.0005428. eCollection 2017 Apr.

Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis. Willemse S, Smit C, Sogni P, Sarcletti M, Uberti-Foppa C, Wittkop L, Raben D, D'Arminio Monforte A, Dabis F, Van Der Valk M; Hepatocellular Carcinoma Screening Project Working Group for the Collaboration of Observational HIV on behalf of Epidemiological Research Europe (COHERE) In EuroCoord. J Viral Hepat. 2019 May 28. doi: 10.1111/jvh.13146. [Epub ahead of print] No abstract available.

Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations. Laut KG, Shepherd L, Gottfredsson M, Sedlacek D, Knysz B, Begovac J, Radoi R, Schmied B, Chkhartishvili N, Florence E, Ristola M, Fätkenheuer G, Mulcahy F, Schmid P, Kuzovatova E, Paduta D, Smidt J, Domingo P, Szlávik J, Lundgren J, Mocroft A, Kirk O; EuroSIDA study group. AIDS. 2018 Nov 28;32(18):2807-2819. doi: 10.1097/QAD.0000000000002035.

 

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals. Peters L, Laut K, Resnati C, Del Campo S, Leen C, Falconer K, Trofimova T, Paduta D, Gatell J, Rauch A, Lacombe K, Domingo P, Chkhartishvili N, Zangerle R, Matulionyte R, Mitsura V, Benfield T, Zilmer K, Khromova I, Lundgren J, Rockstroh J, Mocroft A; EuroSIDA Study Group. AIDS. 2018 Sep 10;32(14):1995-2004. doi: 10.1097/QAD.0000000000001928.

Improving HIV service delivery for people who inject drugs in Kazakhstan: study protocol for the Bridge stepped-wedge trial. McCrimmon T, Gilbert L, Hunt T, Terlikbayeva A, Wu E, Darisheva M, Primbetova S, Kuskulov A, Davis A, Dasgupta A, Schackman BR, Metsch LR, Feaster DJ, Baiserkin B, El-Bassel N. Implement Sci. 2019 Jun 14;14(1):62. doi: 10.1186/s13012-019-0909-z.

 

Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan. Stringer KL, Mukherjee T, McCrimmon T, Terlikbayeva A, Primbetovac S, Darisheva M, Hunt T, Gilbert L, El-Bassel N. Int J Drug Policy. 2019 Jun;68:27-36. doi: 10.1016/j.drugpo.2019.02.007. Epub 2019 Apr 10.

 

Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan. Davis A, McCrimmon T, Dasgupta A, Gilbert L, Terlikbayeva A, Hunt T, Primbetova S, Wu E, Darisheva M, El-Bassel N. Int J Drug Policy. 2018 Dec;62:43-50. doi: 10.1016/j.drugpo.2018.08.014. Epub 2018 Oct 22.

High Yield of Active Tuberculosis Case Finding Among HIV-Infected Patients Using Xpert MTB/RIF Testing. Kempker RR, Chkhartishvili N, Kinkladze I, Schechter MC, Harrington K, Rukhadze N, Dzigua L, Tserstvadze T, Del Rio C, Blumberg HM, Tukvadze N. Open Forum Infect Dis. 2019 May 17;6(6):ofz233. doi: 10.1093/ofid/ofz233. eCollection 2019 Jun.

Leading causes of death of women of reproductive age in the Republic of Georgia: findings from the National Reproductive Age Mortality Survey (2014). Lomia N, Berdzuli N, Sturua L, Kereselidze M, Topuridze M, Pestvenidze E, Stray-Pedersen B. Int J Womens Health. 2018 Aug 15;10:437-452. doi: 10.2147/IJWH.S164053. eCollection 2018.

Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine. Zelenev A, Shea P, Mazhnaya A, Rozanova J, Madden L, Marcus R, Altice FL. Drug Alcohol Depend. 2018 Sep 1;190:82-88. doi: 10.1016/j.drugalcdep.2018.05.027. Epub 2018 Jun 30.

 

Association between injection in public places and HIV/HCV risk behavior among people who use drugs in Ukraine. Mazhnaya A, Tobin KE, Owczarzak J. Drug Alcohol Depend. 2018 Aug 1;189:125-130. doi: 10.1016/j.drugalcdep.2018.04.036. Epub 2018 Jun 8.

 

Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine. Iakunchykova O, Meteliuk A, Zelenev A, Mazhnaya A, Tracy M, Altice FL. Int J Drug Policy. 2018 Jul;57:11-17. doi: 10.1016/j.drugpo.2018.03.022. Epub 2018 Apr 12.

Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes. Mazhnaya A, Meteliuk A, Barnard T, Zelenev A, Filippovych S, Altice FL. Int J Drug Policy. 2017 Sep;47:187-195. doi: 10.1016/j.drugpo.2017.07.023. Epub 2017 Aug 12.

 

An Innovative Study Design to Assess the Community Effect of Interventions to Mitigate HIV Epidemics Using Transmission-Chain Phylodynamics. Magiorkinis G, Karamitros T, Vasylyeva TI, Williams LD, Mbisa JL, Hatzakis A, Paraskevis D, Friedman SR. Am J Epidemiol. 2018 Dec 1;187(12):2615-2622. doi: 10.1093/aje/kwy160.

 

Network Research Experiences in New York and Eastern Europe: Lessons for the Southern US in Understanding HIV Transmission Dynamics. Friedman SR, Williams L, Young AM, Teubl J, Paraskevis D, Kostaki E, Latkin C, German D, Mateu-Gelabert P, Guarino H, Vasylyeva TI, Skaathun B, Schneider J, Korobchuk A, Smyrnov P, Nikolopoulos G. Curr HIV/AIDS Rep. 2018 Jun;15(3):283-292. doi: 10.1007/s11904-018-0403-2. Review.

 

Risk network approaches to locating undiagnosed HIV cases in Odessa, Ukraine. Smyrnov P, Williams LD, Korobchuk A, Sazonova Y, Nikolopoulos GK, Skaathun B, Morgan E, Schneider J, Vasylyeva TI, Friedman SR. J Int AIDS Soc. 2018 Jan;21(1). doi: 10.1002/jia2.25040.

 

Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine. Vasylyeva TI, Liulchuk M, Friedman SR, Sazonova I, Faria NR, Katzourakis A, Babii N, Scherbinska A, Thézé J, Pybus OG, Smyrnov P, Mbisa JL, Paraskevis D, Hatzakis A, Magiorkinis G. Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1051-1056. doi: 10.1073/pnas.1701447115. Epub 2018 Jan 16.

Factors affecting development of Clostridium difficile infection in hospitalized pediatric patients in the country Georgia. Migriauli I, Meunargia V, Chkhaidze I, Sabakhtarishvili G, Gujabidze K, Butsashvili M, Kamkamidze G. BMC Res Notes. 2018 Jun 26;11(1):409. doi: 10.1186/s13104-018-3517-0.

Until people start dying in droves, no actions will be taken": perception and experience of HIV-preventive measures among people who inject drugs in northwestern Russia.  Meylakhs, Peter, Grønningsæter, Arne, Aasland, Aadne. Harm Reduct J. 2017 Jun 5;14(1):33. doi: 10.1186/s12954-017-0162-1.  

A review of lesbian, gay, bisexual, trans and intersex (LGBTI) health and healthcare inequalities. Zeeman, Laetitia, Sherriff, Nigel; Browne, Kath; McGlynn, Nick; Mirandola, Massimo; Gios, Lorenzo; Davis, Ruth; Sanchez-Lambert, Juliette; Aujean, Sophie; Pinto, Nuno; Farinella, Francesco; Donisi, Valeria; Niedzwiedzka-Stadnik, Marta; Rosinska, Magdalena; Pierson, Anne; Amaddeo, Francesco. Eur J Public Health. 2019 Oct 1;29(5):974-980. doi: 10.1093/eurpub/cky226. 

Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study. Uusküla, Anneli, Des Jarlais, Don, Raag, Mait, Vorobjov, Sigrid. Harm Reduct J. 2018 Mar 5;15(1):10. doi:10.1186/s12954-018-0215-0.    

Anti-infective activities of 11 plants species used in traditional medicine in Malaysia Nor Azman NS, Hossan MS, Nissapatorn V, Uthaipibull C, Prommana P, Jin KT, Rahmatullah M, Mahboob T, Raju CS, Jindal HM, Hazra B, Mohd Abd Razak MR, Prajapati VK, Pandey RK, Aminudin N, Shaari K, Ismail NH, Butler MS, Zarubaev VV, Wiart C. Exp Parasitol. 2018 Nov; 194:67-78. doi: 10.1016/j.exppara.2018.09.020. Epub 2018 Sep 27.

Anti-influenza activity of diazaadamantanes combined with monoterpene moieties. EvgeniySuslov, Vladimir V.Zarubaev, Alexander V.Slita, KonstantinPonomarev, DinaKorchagina, Daniel M.Ayine-Tora, JóhannesReynisson, KonstantinVolcho, Nariman Salakhutdinov. Bioorganic & Medicinal Chemistry Letters. Volume 27, Issue 19, 1 October 2017, Pages 4531-4535

Assessment of the quality of anti-tuberculosis medicines in Almaty, Kazakhstan, 2014. Nabirova D, Nuorti J P, Schmid G, Yusupova R, Kantarbayeva M, Ismailov S I, Moffett D, Jähnke RWO. The International Journal of Tuberculosis and Lung Disease, Volume 21, Number 10, 1 October 2017, pp. 1161-1168(8)

Behavioural and demographic correlates of undiagnosed HIV infection in a MSM sample recruited in 13 European cities.   Marcus, Ulrich, Nöstlinger, Christiana; Rosińska, Magdalena; Sherriff, Nigel; Gios, Lorenzo; Dias, Sonia F; Gama, Ana F; Toskin, Igor; Alexiev, Ivailo; Naseva, Emilia; Schink, Susanne Barbara; Mirandola, Massimo. BMC Infect Dis. 2018 Aug 6;18(1):368. doi: 10.1186/s12879-018-3249-8.

CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus. Ghosn, Jade, Bayan, Tatiana; Meixenberger, Karolin; Tran, Laurent; Frange, Pierre; d'Arminio Monforte, Antonella; Zangerle, Robert; de Mendoza, Carmen; Krastinova, Evguenia; Porter, Kholoud; Meyer, Laurence; Chaix, Marie-Laure. J Antimicrob Chemother. 2017 Oct 1;72(10):2862-2868. doi: 10.1093/jac/dkx247.    

Comparison of early detection of Fasciola hepatica in experimentally infected Merino sheep by real-time PCR, coproantigen ELISA and sedimentation. Calvani NED, Šlapeta J, George SD, Windsor PA, Bush, RD. Vet Parasitol. 2018 Feb 15;251:85-89. doi: 10.1016/j.vetpar.2018.01.004. Epub 2018 Jan 3.

Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage. Võrno T, Lutsar K, Uusküla A, Padrik L, Raud T, Reile R, Nahkur O, Kiivet RA. Vaccine. 2017 Nov 1;35(46):6329-6335. doi: 10.1016/j.vaccine.2017.08.083. Epub 2017 Sep 9.

Design of a randomized controlled trial of zinc supplementation to improve markers of mortality and HIV disease progression in HIV-positive drinkers in St. Petersburg, Russia. Gnatienko NFreiberg MSBlokhina EYaroslavtseva TBridden CCheng DMChaisson CELioznov DBendiks SKoerbel GColeman SMKrupitsky ESamet JH. HIV Clin Trials. 2018 Jun;19(3):101-111. doi: 10.1080/15284336.2018.1459344. Epub 2018 Apr 17.

Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia. IsabelTavitian-Exley, MathieuMaheu-Giroux, LucyPlatt, RobertHeimer, AnneliUusküla, OlgaLevina, PeterVickerman, Marie-ClaudeBoily.  Int J Drug Policy. 2018 Mar;53:96-105. doi: 10.1016/j.drugpo.2017.11.010. Epub 2018 Jan 5.

Direct acting antiviral-based treatment of hepatitis C virus infection among people who inject drugs in Georgia: A prospective cohort study. Bouscaillou JKikvidze TButsashvili MLabartkava KInaridze IEtienne ALe Pluart DKamkamidze GGamezardashvili AKharshiladze DAvril ELuhmann N. Int J Drug Policy. 2018 Dec;62:104-111. doi: 10.1016/j.drugpo.2018.07.016. Epub 2018 Oct 30.

Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines. Olena Sapega, Milan Reiniš, Romana Mikyšková, Jana Bieblová, Blanka Mrázková, Zdeněk Hodný.  Int J Oncol. 2018 Nov; 53(5): 1997–2009. Published online 2018 Sep 5. doi: 10.3892/ijo.2018.4553

 

Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla-Järve, Estonia.  Robert HeimerNina UsachevaRussell BarbourLinda M. NiccolaiAnneli Uuskula, and Olga S. Levina. Addiction. 2017 Aug; 112(8): 1421–1431. Published online 2017 May 4.  

doi: 10.1111/add.13798

Factors associated with hepatitis C prevalence differ by the stage of liver fibrosis: A cross-sectional study in the general population in Poland, 2012-2016. Magdalena RosińskaNatalia PardaAgnieszka KołakowskaPaulina GodzikKarolina ZakrzewskaKazimierz MadalińskiAndrzej ZielińskiAnna BoguradzkaRafał GierczyńskiMałgorzata StępieńPLoS One. 2017; 12(9): e0185055. Published online 2017 Sep 20. doi: 10.1371/journal.pone.0185055

Frequency and factors associated with providing injection initiation assistance in Tallinn, Estonia. Anneli Uusküla, David M Barnes, Mait Raag, Ave Talu, Susan Tross, Don C Des Jarlais. Drug and Alcohol Dependence. Volume 188, 1 July 2018, Pages 64-70.

 

Gaps in understanding factors influencing tuberculosis recurrence. Somoskovi Akos, Gutierrez Cristina. The international journal of tuberculosis and lung disease Volume 22, Number 8, 1 August 2018, pp. 830-830(1)

 

Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015.  Kivimets K, Uusküla A, Lazarus JV, Ott K. BMC Infect Dis. 2018 Jul 21;18(1):339. doi: 10.1186/s12879-018-3242-2.

 

Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use. Don C. Des Jarlais, K Arasteh, J. Feelemyer,C. McKnight, David M Barnes, David C Perlman, A Uuskula, HLF Cooper, Susan Tross.  Drug and Alcohol Dependence. Volume 192, 1 November 2018, Pages 74-79.

HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay. Soodla P, Simmons R; Huik K; Pauskar M; Jõgeda E-L; Rajasaar H; Kallaste E; Maimets M; Avi R; Murphy G; Porte, K; Lutsar I. HIV Med. 2018 Jan;19(1):33-41. doi: 10.1111/hiv.12535. Epub 2017 Aug 1.

HIV prevalence and gender differences among new injection-drug users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic. Anneli Uusküla, Mait Raag, Kristina Marsh, Ave Talu, Sigrid Vorobjov, Don Des Jarlais. PLoS One. 2017; 12(2): e0170956. Published online 2017 Feb 2. doi: 10.1371/journal.pone.0170956

 

HIV Stigma and Substance Use among HIV-Positive Russians with Risky Drinking. E. Jennifer Edelman, Karsten Lunze, Debbie M. Cheng, Dmitry A. Lioznov, Emily Quinn, Natalia Gnatienko, Carly Bridden, Christine E. Chaisson, Alexander Y. Walley, Evgeny M. Krupitsky, Anita Raj, Jeffrey H. Samet AIDS Behav. Author manuscript; available in PMC 2018 Sep 1. Published in final edited form as: AIDS Behav. 2017 Sep; 21(9): 2618–2627. doi: 10.1007/s10461-017-1832-4

HIV Stigma and Unhealthy Alcohol Use Among People Living with HIV in Russia. Karsten Lunze, Dmitry Lioznov, Debbie M. Cheng, Ruslan V. Nikitin, Sharon M. Coleman, Carly Bridden, Elena Blokhina, Evgeny Krupitsky, Jeffrey H. Samet. AIDS Behav. 2017 Sep; 21(9): 2609–2617. doi: 10.1007/s10461-017-1820-8

 

Impact of illicit opioid use on T cell subsets among HIV-infected adults. Edelman EJ, So-Armah K, Cheng DM, Doyle MF, Coleman Sm, Bridden C, Gnatienko N, Lioznov DA, Blokhina E, Freiberg MS, Krupitsky, EM, Emu B, Samet, JH. PLoS One. 2017 May 4;12(5):e0176617. doi: 10.1371/journal.pone.0176617. eCollection 2017.  

Is medical marijuana legalisation possible in Poland?  Dorota Rogowska-Szadkowska, Julia Strumiło, Sławomir Chlabicz. Cent Eur J Public Health 2018; 26 (1): 45–48.

 

Mycobacterium tuberculosis RD-Rio Strain in Kazakhstan. Yuriy Skiba, Igor Mokrousov, Dilyara Nabirova, Anna Vyazovaya, Elina Maltseva, Natalya Malakhova, Gulnara Ismagulova, Ilva Pole, Renate Ranka, Zhanar Sapiyeva, Shakhimurat Ismailov, Daphne Moffett. Emerg Infect Dis. 2019 Mar; 25(3): 604–606. doi: 10.3201/eid2503.181179

New HIV diagnoses among adults aged 50 years or older in 31 European countries, 2004-15: an analysis of surveillance data. Tavoschi LGomes Dias JPharris AEU/EEA HIV Surveillance Network. Lancet HIV. 2017 Nov;4(11):e514-e521. doi: 10.1016/S2352-3018(17)30155-8. Epub 2017 Sep 26.

 

Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria. Forbes BA, Hall GS, Miller MB, Novak SM, Rowlinson MC, Salfinger M, Somoskövi A, Warshauer DM, Wilson ML. Clin Microbiol Rev. 2018 Jan 31;31(2). pii: e00038-17. doi: 10.1128/CMR.00038-17. Print 2018 Apr. Review.

 

Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future. Dan Werb, R. N. Bluthenthal, G. Kolla, C. Strike, A. H. Kral, A. Uusküla, D. Des Jarlais. J Urban Health. 2018 Feb; 95(1): 91–98. Published online 2017 Sep 25. doi: 10.1007/s11524-017-0192-8

Psychological features of abstinent heroin users before and after rehabilitation in Saint Petersburg, Russia. Timofey Galankin, Dmitry Lioznov, Svetlana Nikolaenko, Louise-Anne McNutt, Emily Leckman-Westin, Perry F. Smith. BMC Res Notes. 2018; 11: 589. Published online 2018 Aug 14. doi: 10.1186/s13104-018-3699-5

Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia. Bulat Idrisov, Karsten Lunze, Debbie M. Cheng, Elena Blokhina, Natalia Gnatienko, Emily Quinn, Carly Bridden, Alexander Y. Walley, Kendall J. Bryant, Dmitry Lioznov, Evgeny Krupitsky, Jeffrey H. Samet. Addict Sci Clin Pract. 2017; 12: 30. Published online 2017 Dec 4. doi: 10.1186/s13722-017-0098-5

Towards standardized definitions for monitoring the continuum of HIV care in Europe. Annabelle J Gourlay, Anastasia M Pharris, Teymur Noori, Virginie Supervie, Magdalena Rosinska, Ard van Sighem, Giota Touloumi, and Kholoud Porter. AIDS. 2017 Sep 24; 31(15): 2053–2058. Published online 2017 Sep 13. doi: 10.1097/QAD.0000000000001597

Treatment of chlamydia and gonorrhoea, compliance with treatment guidelines and factors associated with non-compliant prescribing: findings form a cross-sectional study. Tisler-Sala A, Ojavee, SE, Uusküla A. Sex Transm Infect. 2018 Jun;94(4):298-303. doi: 10.1136/sextrans-2017-053247. Epub 2017 Oct 24.    

Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Järve region of Estonia. Wu J,  Crawford FW, Raag, M; Heimer R, Uusküla, A. PLoS One. 2017; 12(11): e0185711. Published online 2017 Nov 2. doi: 10.1371/journal.pone.0185711

Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine. Vasylyeva TILiulchuk MFriedman SRSazonova IFaria NRKatzourakis ABabii NScherbinska AThézé JPybus OGSmyrnov PMbisa JLParaskevis DHatzakis AMagiorkinis G. Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1051-1056. doi:

10.1073/pnas.1701447115. Epub 2018 Jan 16.

 

©2019 by STAR PROGRAM  media and marketing department.